These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 31795416

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant.
    Hsiao HT, Wang JC, Wu SN.
    Biomedicines; 2022 Jun 03; 10(6):. PubMed ID: 35740340
    [Abstract] [Full Text] [Related]

  • 24. The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia.
    Su K, Li Z, Yu Y, Zhang X.
    Drug Discov Today; 2020 Jul 03; 25(7):1262-1269. PubMed ID: 32380083
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes.
    Chang WT, Liu PY, Wu SN.
    Molecules; 2020 Oct 02; 25(19):. PubMed ID: 33023219
    [Abstract] [Full Text] [Related]

  • 27. Hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat (FG-4592) alleviates sepsis-induced acute lung injury.
    Han F, Wu G, Han S, Li Z, Jia Y, Bai L, Li X, Wang K, Yang F, Zhang J, Wang X, Guan H, Linlin S, Han J, Hu D.
    Respir Physiol Neurobiol; 2020 Oct 02; 281():103506. PubMed ID: 32726645
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of nalbuphine, a κ-opioid receptor agonist and μ-opioid receptor antagonist, in the inhibition of INa , IK(M) , and IK(erg) unlinked to interaction with opioid receptors.
    Liu YY, Hsiao HT, Wang JC, Liu YC, Wu SN.
    Drug Dev Res; 2019 Sep 02; 80(6):846-856. PubMed ID: 31301190
    [Abstract] [Full Text] [Related]

  • 29. High Capability of Pentagalloylglucose (PGG) in Inhibiting Multiple Types of Membrane Ionic Currents.
    Chang WT, Liu PY, Wu SN.
    Int J Mol Sci; 2020 Dec 09; 21(24):. PubMed ID: 33316951
    [Abstract] [Full Text] [Related]

  • 30. Evidence for state-dependent block of DPI 201-106, a synthetic inhibitor of Na+ channel inactivation, on delayed-rectifier K+ current in pituitary tumor (GH3) cells.
    Wang YJ, Lin MW, Lin AA, Peng H, Wu SN.
    J Physiol Pharmacol; 2008 Sep 09; 59(3):409-23. PubMed ID: 18953087
    [Abstract] [Full Text] [Related]

  • 31. Effective Activation by Kynurenic Acid and Its Aminoalkylated Derivatives on M-Type K+ Current.
    Lo YC, Lin CL, Fang WY, Lőrinczi B, Szatmári I, Chang WH, Fülöp F, Wu SN.
    Int J Mol Sci; 2021 Jan 28; 22(3):. PubMed ID: 33525680
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness in the inhibition of dapagliflozin and canagliflozin on M-type K+ current and α-methylglucoside-induced current in pituitary tumor (GH3) and pheochromocytoma PC12 cells.
    So EC, Liu PY, Wu SN.
    Eur J Pharmacol; 2020 Jul 15; 879():173141. PubMed ID: 32353360
    [Abstract] [Full Text] [Related]

  • 33. Concerted suppression of Ih and activation of IK(M) by ivabradine, an HCN-channel inhibitor, in pituitary cells and hippocampal neurons.
    Hsiao HT, Liu YC, Liu PY, Wu SN.
    Brain Res Bull; 2019 Jul 15; 149():11-20. PubMed ID: 30951796
    [Abstract] [Full Text] [Related]

  • 34. Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of I K(M) or I K(DR) and in the Stimulation of I MEP.
    Chang WT, Liu PY, Gao ZH, Lee SW, Lee WK, Wu SN.
    Front Pharmacol; 2020 Jul 15; 11():1091. PubMed ID: 32792942
    [Abstract] [Full Text] [Related]

  • 35. Development of ionic currents underlying changes in action potential waveforms in rat spinal motoneurons.
    Gao BX, Ziskind-Conhaim L.
    J Neurophysiol; 1998 Dec 15; 80(6):3047-61. PubMed ID: 9862905
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of delayed rectifier K(+)-current by levcromakalim in single intestinal smooth muscle cells: effects of cations and dependence on K(+)-flux.
    McHugh D, Beech DJ.
    Br J Pharmacol; 1995 Jan 15; 114(2):391-9. PubMed ID: 7881739
    [Abstract] [Full Text] [Related]

  • 37. Activation of Voltage-Gated Na+ Current by GV-58, a Known Activator of CaV Channels.
    Cho HY, Chen PC, Chuang TH, Yu MC, Wu SN.
    Biomedicines; 2022 Mar 20; 10(3):. PubMed ID: 35327523
    [Abstract] [Full Text] [Related]

  • 38. Electrophysiological properties of paraventricular magnocellular neurons in rat brain slices: modulation of IA by angiotensin II.
    Li Z, Ferguson AV.
    Neuroscience; 1996 Mar 20; 71(1):133-45. PubMed ID: 8834397
    [Abstract] [Full Text] [Related]

  • 39. Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor.
    Groenendaal-van de Meent D, Adel MD, Noukens J, Rijnders S, Krebs-Brown A, Mateva L, Alexiev A, Schaddelee M.
    Clin Drug Investig; 2016 Sep 20; 36(9):743-751. PubMed ID: 27352308
    [Abstract] [Full Text] [Related]

  • 40. Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.
    Besarab A, Provenzano R, Hertel J, Zabaneh R, Klaus SJ, Lee T, Leong R, Hemmerich S, Yu KH, Neff TB.
    Nephrol Dial Transplant; 2015 Oct 20; 30(10):1665-73. PubMed ID: 26238121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.